A differential network approach to exploring differences between biological states: An application to prediabetes

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Valcárcel, Beatriz ^a   Würtz, Peter ^a,b   al Basatena, Nafisa Katrin Seich ^a   Tukiainen, Taru ^a,b   Kangas, Antti J ^b   Soininen, Pasi ^b,c   Järvelin, Marjo Riitta ^a,b,d   Ala Korpela, Mika ^b,c   Ebbels, Timothy M ^a   de Iorio, Maria ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MOLECULAR BIOLOGY; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN ANALYSIS; STATISTICAL ANALYSIS;

BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; FINLAND; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, BIOLOGICAL; MODELS, GENETIC; MODELS, STATISTICAL; PHENOTYPE; SYSTEMS BIOLOGY;

EID: 80053202843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024702     Document Type: Article

References (32)

1. Barabasi AL, Albert R, (1999) Emergence of scaling in random networks. Science 286 (5439): 509-512.
2. Barabasi AL, Oltvai ZN, (2004) Network biology: Understanding the cell's functional organization. Nat Rev Genet 5 (2): 101-113.
3. Steuer R, (2006) Review: On the analysis and interpretation of correlations in metabolomic data. Brief Bioinform 7 (2): 151-158.
4. Camacho D, de lF, Mendes P, (2005) The origin of correlations in metabolomics data. Metabolomics 1 (1): 53-63.
5. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, et al. (2009) Metabolomics applied to diabetes research: Moving from information to knowledge. Diabetes 58 (11): 2429-2443.
6. Oldham MC, Horvath S, Geschwind DH, (2006) Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc Natl Acad Sci U S A 103 (47): 17973-17978.
7. Fuller TF, Ghazalpour A, Aten JE, Drake TA, Lusis AJ, et al. (2007) Weighted gene coexpression network analysis strategies applied to mouse weight. Mamm Genome 18 (6-7): 463-472.
8. Fuite J, Vernon SD, Broderick G, (2008) Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: An exploratory analysis. Genomics 92 (6): 393-399.
9. Gill R, Datta S, Datta S, (2010) A statistical framework for differential network analysis from microarray data. BMC Bioinformatics 11 (1): 95.
10. Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, et al. (2005) Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study. Circulation 111 (25): 3465-3472.
11. Hegele RA, (2009) Plasma lipoproteins: Genetic influences and clinical implications. Nat Rev Genet 10 (2): 109-121.
12. de Silva E, Stumpf MP, (2005) Complex networks and simple models in biology. J R Soc Interface 2 (5): 419-430.
13. Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, et al. (2010) Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol 6: 441.
14. Wagner A, Fell DA, (2001) The small world inside large metabolic networks. Proc Biol Sci 268 (1478): 1803-1810.
15. Ursem R, Tikunov Y, Bovy A, van Berloo R, van Eeuwijk F, (2008) A correlation network approach to metabolic data analysis for tomato fruits. Euphytica 161 (1): 181-193.
16. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL, (2002) Hierarchical organization of modularity in metabolic networks. Science 297 (5586): 1551-1555.
17. Kumpula LS, Kumpula JM, Taskinen MR, Jauhiainen M, Kaski K, et al. (2008) Reconsideration of hydrophobic lipid distributions in lipoprotein particles. Chem Phys Lipids 155 (1): 57-62.
18. de la Fuente A, Bing N, Hoeschele I, Mendes P, (2004) Discovery of meaningful associations in genomic data using partial correlation coefficients. Bioinformatics 20 (18): 3565-3574.
19. Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, et al. (2010) Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes 59 (5): 1153-1160.
20. World Health Organization (2003) Screening for type 2 diabetes: report of a WHO/IDF meeting. Geneva. WHO/NMH/MN/03.1.
21. Hodge AM, Jenkins AJ, English DR, O'Dea K, Giles GG, (2009) NMR-determined lipoprotein subclass profile predicts type 2 diabetes. Diabetes Res Clin Pract 83 (1): 132-139.
22. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, et al. (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49 (4): 755-765.
23. Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, et al. (2009) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41 (1): 35-46.
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (Suppl 1): S5-20.
25. Bertram HC, Duus JO, Petersen BO, Hoppe C, Larnkjaer A, et al. (2009) Nuclear magnetic resonance-based metabonomics reveals strong sex effect on plasma metabolism in 17-year-old scandinavians and correlation to retrospective infant plasma parameters. Metabolism 58 (7): 1039-1045.
26. Soininen P, Kangas AJ, Würtz P, Tukiainen T, Tynkkynen T, et al. (2009) High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 134 (9): 1781-1785.
27. Vehtari A, Mäkinen VP, Soininen P, Ingman P, Mäkelä SM, et al. (2007) A novel bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data. BMC Bioinformatics 8 (Suppl 2): S8.
28. Niemi J, Mäkinen VP, Heikkonen J, Tenkanen L, Hiltunen Y, et al. (2009) Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the friedewald inputs-apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes. Ann Med 41 (6): 451-461.
29. de la Fuente A, Bing N, Hoeschele I, Mendes P, (2004) Discovery of meaningful associations in genomic data using partial correlation coefficients. Bioinformatics 20 (18): 3565-3574.
30. Schäfer J, Strimmer K, (2005) A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics. Statistical Applications in Genetics and Molecular Biology 4.
31. Ledoit O, Wolf M, (2003) Improved estimation of the covariance matrix of stock returns with an application to portfolio selection. Journal of Empirical Finance 10 (5): 603-621.
32. de Silva E, Stumpf MP, (2005) Complex networks and simple models in biology. J R Soc Interface 2 (5): 419-430.